GSK-3抑制剂II结构式
|
常用名 | GSK-3抑制剂II | 英文名 | GSK3β inhibitor II |
---|---|---|---|---|
CAS号 | 478482-75-6 | 分子量 | 395.21800 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C14H10IN3OS | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
GSK-3抑制剂II用途GSK3β抑制剂II是一种GSK3α的抑制剂。GSK3β抑制剂II可用于阿尔茨海默病(AD)的研究[1]。 |
中文名 | GSK-3抑制剂II |
---|---|
英文名 | 2-[(3-iodophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole |
英文别名 | 更多 |
描述 | GSK3β抑制剂II是一种GSK3α的抑制剂。GSK3β抑制剂II可用于阿尔茨海默病(AD)的研究[1]。 |
---|---|
相关类别 | |
靶点 |
GSK-3β |
体外研究 | GSK3β抑制剂II与 Ile62、Phe67、Val70、Ala83和 亮氨酸188具有疏水相互作用,与 赖氨酸85具有离子相互作用,以及与 赖氨酸85和 阀门135残基具有氢键相互作用[1]。 GSK3β抑制剂II与 阀门135[1]形成氢键。 |
参考文献 |
分子式 | C14H10IN3OS |
---|---|
分子量 | 395.21800 |
精确质量 | 394.95900 |
PSA | 77.11000 |
LogP | 4.02850 |
~% GSK-3抑制剂II 478482-75-6 |
文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
~% GSK-3抑制剂II 478482-75-6 |
文献:Narum, Lars; Norskov-Lauritsen, Leif; Olesen, Preben H. Bioorganic and Medicinal Chemistry Letters, 2002 , vol. 12, # 11 p. 1525 - 1528 |
~% GSK-3抑制剂II 478482-75-6 |
文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
~% GSK-3抑制剂II 478482-75-6 |
文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
~% GSK-3抑制剂II 478482-75-6 |
文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
~% GSK-3抑制剂II 478482-75-6 |
文献:Lukas, Thomas J.; Schiltz, Gary E.; Arrat, Hasan; Scheidt, Karl; Siddique, Teepu Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 6 p. 1532 - 1537 |
GSK-3抑制剂II上游产品 6 | |
---|---|
GSK-3抑制剂II下游产品 0 |
GSK-3b Inhibitor II |
Glycogen Synthase Kinase-3beta Inhibitor II |
GSK-3 Inhibitor II |
GSK-3beta Inhibitor II |
2-(3-iodobenzylthio)-5-(pyridin-4-yl)-1,3,4-oxadiazole |
2-thio(3-iodobenzyl)-5-(1-pyridyl)-[1,3,4]oxadiazole |
HMS3229G14 |